查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
單核細胞增多症診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、最終用戶和地理位置
市場調查報告書
商品編碼
1624233

單核細胞增多症診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、最終用戶和地理位置

Mononucleosis Diagnostic Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 訂單完成後即時交付

價格

依據「2031 年單核細胞增多症診斷市場預測 - 全球分析 - 按類型、最終用戶和地理位置」的新研究，該市場預計將從 2023 年的 1.5144 億美元成長到 2.2215 億美元到2031 年；預計 2023 年至 2031 年複合年成長率為 4.9%。青少年族群的高風險以及對單核細胞增多症的健康意識和知識的不斷提高，導致單核細胞增多症診斷市場規模不斷擴大。然而，現有診斷測試的準確性較低阻礙了單核細胞增多症診斷市場的成長。此外，單核細胞增多症診斷中分子診斷的進步預計將在未來幾年帶來新的單核細胞增多症診斷市場趨勢。

就收入而言，北美將在 2023 年主導單核細胞增多症診斷市場。美國是世界上最大的單核細胞增多症診斷市場，預計在預測期內也將主導該市場。美國單核細胞增多症診斷市場的成長歸因於技術進步、意識提高以及對有效疾病管理策略的持續需求。根據美國國立衛生研究院的數據，美國每年記錄約 125,000 例傳染性單核球增多症病例。由於如此高的數字，該國對EB病毒（EBV）引起的單核細胞增多症的認知也在提高，這增加了對快速、準確的診斷檢測試劑盒、耗材和服務的需求。該國醫療保健提供者採用的各種檢測方法包括基於抗體檢測的血清學檢測和專注於病毒 DNA 識別的分子檢測。美國單核細胞增多症診斷市場的競爭格局由雅培實驗室、羅氏診斷和西門子醫療等公司主導。這些公司投資於創新和合作，以增強其產品供應並擴大其市場佔有率。

單核球增多症診斷市場分析

床邊檢測的發展為未來提供市場機會

POC 測試可以在患者護理現場或附近進行快速診斷，使醫療保健提供者能夠立即做出臨床決策並改善患者治療結果。傳統的實驗室測試通常需要數小時或數天才能得出結果，這可能會延遲治療並使症狀惡化。相較之下，POC 測試可以在幾分鐘內得出結果，以便及時介入。快速週轉對於單核細胞增多症等疾病尤其重要，因為早期診斷可以減少併發症並提高患者的舒適度。 POC 測試可以在各種醫療機構中實施，包括門診診所、急診室和家庭護理機構。對於實驗室基礎設施有限的地區或醫療資源不足的農村地區，這種便利性尤其有利。以 POC 測試的形式使診斷能力更接近患者，確保更多的人得到及時的診斷和適當的護理，從而擴大醫療保健服務的範圍。此外，這種類型的測試促進了更大的參與度，因為患者可以快速收到結果並與醫療保健提供者討論後續步驟。

與傳統實驗室測試相比，POC 測試更具成本效益，因為它們不需要大量的實驗室基礎設施，從而降低了醫療保健系統的整體成本。單核細胞增多症檢測的可負擔性進一步推動了更廣泛的患者的可及性，特別是在服務不足的人群中。生物感測器和微流體技術的最新進展正在推動更複雜的 POC 測試的發展，並提高靈敏度和特異性。這些創新確保了 POC 檢測檢測單核細胞增多症的可靠性。提供 POC 檢測試劑盒的單核細胞增多症診斷市場參與者包括 SEKISUI Diagnostics (OSOM Mono Test)、Abbott (Clearview Mono) 和 Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]。因此，POC 測試的發展為單核細胞增多症診斷市場參與者帶來了巨大的成長機會。

單核細胞增多症診斷市場報告細分分析

有助於單核細胞增多症診斷市場分析的關鍵部分是類型和最終用戶。

根據類型，單核球增多症診斷市場分為EB病毒抗體檢測、全血球計數檢測及單點檢測。 2023 年，單點測試領域佔據了最大的單核細胞增多症診斷市場。

就最終用戶而言，單核細胞增多症診斷市場分為醫院、實驗室等。 2023 年，醫院細分市場將主導市場。

單核細胞增多症診斷市場：競爭格局與主要發展

Abbott Laboratories、Arlington Scientific Inc、Bio-Rad Laboratories Inc、Cardinal Health Inc、Meridian Bioscience Inc、Sekisui Diagnostics LLC、Thermo Fisher Scientific Inc、QuidelOrtho Corp、F. Hoffmann-La Roche Ltd、QIAGEN NV、Hologic Inc、bioieux Ltd、 DiaSorin SpA、Immunostics Inc.、Launch Diagnostics Ltd、Biorex Diagnostics 和ZEUS Scientific 是單核細胞增多症診斷市場的主要公司之一。

聯合國兒童基金會(UNICEF)、國家醫學圖書館、疾病管制與預防中心(CDC)、美國國立衛生研究院、加拿大統計局、聯邦統計局(Destatis) 是準備報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：單核球增多症診斷市場格局

  • 概述
  • PEST分析

第 5 章：單核球增多症診斷市場 - 主要市場動態

  • 單核球增多症診斷市場 - 主要市場動態
  • 市場促進因素
    • 青少年族群的高風險
    • 關於單核細胞增多症的健康意識和知識不斷提高
  • 市場限制
    • 現有診斷測試的準確性較低
  • 市場機會
    • 即時檢測的發展
  • 未來趨勢
    • 分子診斷的進展
  • 促進因素和限制的影響：

第 6 章：單核球增多症診斷市場 - 全球市場分析

  • 單核球增多症診斷市場收入，2021-2031
  • 單核球增多症診斷市場預測分析

第 7 章：單核球增多症診斷市場分析 - 按類型

  • 單點測試
  • Epstein 病毒抗體檢測
  • 全血球計數測試

第 8 章：單核球增多症診斷市場分析 - 依最終用戶

  • 醫院
  • 實驗室
  • 其他

第 9 章：單核球增多症診斷市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：產業格局

  • 概述
  • 單核球增多症診斷市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 11 章：公司簡介

  • Abbott Laboratories
  • Arlington Scientific Inc
  • Bio-Rad Laboratories Inc
  • Cardinal Health Inc
  • Meridian Bioscience Inc
  • Sekisui Diagnostics LLC
  • Thermo Fisher Scientific Inc
  • QuidelOrtho Corp
  • F. Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Hologic Inc
  • bioMerieux SA
  • DiaSorin SpA
  • Immunostics Inc.
  • Launch Diagnostics Ltd
  • Biorex Diagnostics
  • ZEUS Scientific

第 12 章：附錄

Product Code: TIPRE00019689

According to our new research study on "Mononucleosis Diagnostic Market Forecast to 2031 -Global Analysis - by Type, End User, and Geography," the market is anticipated to grow from US$ 151.44 million in 2023 and is projected to reach US$ 222.15 million by 2031; it is expected to register a CAGR of 4.9% during 2023-2031. High risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are contributing to the growing mononucleosis diagnostic market size. However, the low accuracy of existing diagnostic tests hampers the mononucleosis diagnostic market growth. Further, advancements in molecular diagnostics in mononucleosis diagnostic are expected to bring in new mononucleosis diagnostic market trends in the coming years.

In terms of revenue, North America dominated the mononucleosis diagnostic market in 2023. It is estimated to dominate the global market during the forecast period. The US is the largest market for mononucleosis diagnostics in the world, and it is estimated to dominate the market during the forecast period as well. The mononucleosis diagnostic market growth in the US is attributed to technological advancements, increased awareness, and a constant need for effective disease management strategies. According to the National Institutes of Health, the US records ~125,000 cases of infectious mononucleosis every year. Owing to such a high number, the awareness of the mononucleosis caused by the Epstein-Barr virus (EBV) is also on the rise in the country, which bolsters the demand for rapid and accurate diagnostic test kits, consumables, and services. Various testing methods adopted by healthcare providers in the country include serological tests based on antibody detection and molecular tests focused on viral DNA identification. The competitive landscape of the mononucleosis diagnostics market in the US is dominated by companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. These companies invest in innovation and collaborations to enhance their product offerings and expand their market presence.

Mononucleosis Diagnostic Market Analysis

Development of Point-of-Care Testing to Provide Market Opportunities in Future

POC testing allows for rapid diagnosis at or near the site of patient care, enabling healthcare providers to make immediate clinical decisions and improve patient outcomes. Traditional laboratory tests often require hours or days to generate results, which can delay treatment and worsen symptoms. In contrast, POC tests can deliver results within minutes, facilitating timely intervention. The rapid turnaround is especially crucial for conditions such as mononucleosis, as early diagnosis can reduce complications and enhance patient comfort. POC testing can be implemented in various healthcare settings, including outpatient clinics, emergency departments, and home care settings. The accessibility is particularly beneficial in areas with limited laboratory infrastructure or in rural regions with insufficient healthcare resources. Bringing diagnostic capabilities closer to patients in the form of POC testing ensures that more individuals receive timely diagnoses and appropriate care, thereby broadening the reach of healthcare services. Moreover, this type of testing promotes greater engagement, as patients can receive their results quickly and discuss the next steps with their healthcare providers.

POC testing can be more cost-effective compared to traditional laboratory testing as they don't need extensive laboratory infrastructure, in turn lowering the overall costs for healthcare systems. The affordability of mononucleosis testing further drives its accessibility to a broader range of patients, especially in underserved populations. Recent advancements in biosensors and microfluidic technologies are driving the development of more sophisticated POC tests with improved sensitivity and specificity. These innovations ensure the reliability of POC tests in detecting mononucleosis. Mononucleosis diagnostic market players offering POC test kits include SEKISUI Diagnostics (OSOM Mono Test), Abbott (Clearview Mono), and Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]. Thus, the development of POC testing generates substantial growth opportunities for the mononucleosis diagnostics market players.

Mononucleosis Diagnostic Market Report Segmentation Analysis

Key segments that contributed to the derivation of the mononucleosis diagnostic market analysis are type and end user.

Based on type, the mononucleosis diagnostic market is segmented into Epstein Barr Virus antibody test, complete blood count test, and monospot test. The monospot test segment held the largest mononucleosis diagnostic market share of the market in 2023.

In terms of end user, the mononucleosis diagnostic market is categorized into hospitals, laboratories, and others. The hospitals segment dominated the market in 2023.

Mononucleosis Diagnostic Market: Competitive Landscape and Key Developments

Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key companies operating in the mononucleosis diagnostic market.

The United Nations Children's Fund (UNICEF), National Library of Medicine, Centers for Disease Control and Prevention (CDC), National Institutes of Health, Statistics Canada, Federal Statistical Office (Destatis) are among the primary and secondary sources referred to while preparing the mononucleosis diagnostic market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Mononucleosis Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Mononucleosis Diagnostics Market - Key Market Dynamics

  • 5.1 Mononucleosis Diagnostics Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 High Risk among Adolescent Population
    • 5.2.2 Rising Health Awareness and Knowledge About Mononucleosis
  • 5.3 Market Restraints
    • 5.3.1 Low Accuracy of Existing Diagnostic Tests
  • 5.4 Market Opportunities
    • 5.4.1 Development of Point-of-Care Testing
  • 5.5 Future Trends
    • 5.5.1 Advancements in Molecular Diagnostics
  • 5.6 Impact of Drivers and Restraints:

6. Mononucleosis Diagnostics Market - Global Market Analysis

  • 6.1 Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Mononucleosis Diagnostics Market Forecast Analysis

7. Mononucleosis Diagnostics Market Analysis - by Type

  • 7.1 Monospot Test
    • 7.1.1 Overview
    • 7.1.2 Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Epstein Barr Virus Antibody Test
    • 7.2.1 Overview
    • 7.2.2 Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.3 Complete Blood Count Test
    • 7.3.1 Overview
    • 7.3.2 Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Mononucleosis Diagnostics Market Analysis - by End User

  • 8.1 Hospital
    • 8.1.1 Overview
    • 8.1.2 Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Laboratories
    • 8.2.1 Overview
    • 8.2.2 Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Mononucleosis Diagnostics Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Mononucleosis Diagnostics Market Overview
    • 9.1.2 North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.1.3 North America: Mononucleosis Diagnostics Market Breakdown, by Type
      • 9.1.3.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
    • 9.1.4 North America: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.4.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.1.5 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.1.5.1 United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.1.1 United States: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.1.2 United States: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.5.2 Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.2.1 Canada: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.2.2 Canada: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.5.3 Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.3.1 Mexico: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.3.2 Mexico: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.2 Europe
    • 9.2.1 Europe Mononucleosis Diagnostics Market Overview
    • 9.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.2.1 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.2.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.2.3 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.1.1 Germany: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.1.2 Germany: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.2 United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.2.1 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.2.2 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.3 France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.3.1 France: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.3.2 France: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.4 Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.4.1 Italy: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.4.2 Italy: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.5 Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.5.1 Spain: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.5.2 Spain: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.6 Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.6.1 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.6.2 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Mononucleosis Diagnostics Market Overview
    • 9.3.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.2.1 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.3.2.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.3.3 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.1.1 China: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.1.2 China: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.2 Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.2.1 Japan: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.2.2 Japan: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.3 India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.3.1 India: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.3.2 India: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.4 Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.4.1 Australia: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.4.2 Australia: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.5 South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.5.1 South Korea: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.5.2 South Korea: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.6 Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.6.1 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.6.2 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.4 South and Central America
    • 9.4.1 South and Central America Mononucleosis Diagnostics Market Overview
    • 9.4.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.2.1 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.4.2.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.4.3 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.1.1 Brazil: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.1.2 Brazil: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.4.3.2 Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.2.1 Argentina: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.2.2 Argentina: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.4.3.3 Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.3.1 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.3.2 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Mononucleosis Diagnostics Market Overview
    • 9.5.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.2.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.5.2.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.5.3 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.2 Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.2.1 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.2.2 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.3 South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.3.1 South Africa: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.3.2 South Africa: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.4 United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.4.1 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.4.2 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.5 Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.5.1 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.5.2 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Mononucleosis Diagnostic Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Arlington Scientific Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Bio-Rad Laboratories Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Cardinal Health Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Meridian Bioscience Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Sekisui Diagnostics LLC
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Thermo Fisher Scientific Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 QuidelOrtho Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 F. Hoffmann-La Roche Ltd
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 QIAGEN NV
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Hologic Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 bioMerieux SA
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 DiaSorin SpA
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments
  • 11.14 Immunostics Inc.
    • 11.14.1 Key Facts
    • 11.14.2 Business Description
    • 11.14.3 Products and Services
    • 11.14.4 Financial Overview
    • 11.14.5 SWOT Analysis
    • 11.14.6 Key Developments
  • 11.15 Launch Diagnostics Ltd
    • 11.15.1 Key Facts
    • 11.15.2 Business Description
    • 11.15.3 Products and Services
    • 11.15.4 Financial Overview
    • 11.15.5 SWOT Analysis
    • 11.15.6 Key Developments
  • 11.16 Biorex Diagnostics
    • 11.16.1 Key Facts
    • 11.16.2 Business Description
    • 11.16.3 Products and Services
    • 11.16.4 Financial Overview
    • 11.16.5 SWOT Analysis
    • 11.16.6 Key Developments
  • 11.17 ZEUS Scientific
    • 11.17.1 Key Facts
    • 11.17.2 Business Description
    • 11.17.3 Products and Services
    • 11.17.4 Financial Overview
    • 11.17.5 SWOT Analysis
    • 11.17.6 Key Developments

12. Appendix

  • 12.1 About the Insight Partners
  • 12.2 Glossary of Terms for Mononucleosis Diagnostics Market

List Of Tables

  • Table 1. Mononucleosis Diagnostics Market Segmentation
  • Table 2. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 3. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 4. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 5. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 6. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 7. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 8. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 9. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 10. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 11. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 12. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 13. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 14. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 15. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 16. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 17. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 18. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 19. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 20. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 21. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 22. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 23. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 24. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 25. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 26. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 27. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 28. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 29. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 30. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 31. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 32. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 33. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 34. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 37. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 38. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 39. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 40. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 41. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 42. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 43. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 44. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 45. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 46. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 47. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 48. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Country
  • Table 49. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 50. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 51. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 52. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 53. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 54. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 55. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 56. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 57. Recent Organic Growth Strategies in Mononucleosis Diagnostic Market
  • Table 58. Recent Inorganic Growth Strategies in the Mononucleosis Diagnostic Market
  • Table 59. Glossary of Terms

List Of Figures

  • Figure 1. Mononucleosis Diagnostics Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 6. Mononucleosis Diagnostics Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 10. Mononucleosis Diagnostics Market Share (%) - by End User (2023 and 2031)
  • Figure 11. Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 12. Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 15. North America: Mononucleosis Diagnostics Market Breakdown, by Type (2023 and 2031)
  • Figure 16. North America: Mononucleosis Diagnostics Market Breakdown, by End User (2023 and 2031)
  • Figure 17. North America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 19. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 20. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 21. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 22. Europe: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 24. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 25. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 26. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 27. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 28. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 29. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 30. Asia Pacific: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 32. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 33. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 34. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 37. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 38. South and Central America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 39. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 40. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 41. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 42. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 43. Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 44. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 45. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 46. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 47. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 48. Growth Strategies in Mononucleosis Diagnostic Market